Back
Verrica Pharmaceuticals Stock Price Chart
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner
Buy
55
VRCA
Verrica Pharmaceuticals
Last Price:
7.02
Seasonality Move:
-18.7%
7 Day Trial
ALL ACCESS PASS
$
7
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRCA is experiencing slight buying pressure.
Verrica Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.86 | Sell |
| 20-day SMA: | 6.93 | Sell |
| 50-day SMA: | 5.96 | Buy |
| 200-day SMA: | 5.03 | Buy |
| 8-day EMA: | 6.87 | Sell |
| 20-day EMA: | 6.71 | Buy |
| 50-day EMA: | 6.23 | Buy |
| 200-day EMA: | 5.45 | Buy |
Verrica Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.25 | Buy |
| Relative Strength Index (14 RSI): | 54.8 | Buy |
| Chaikin Money Flow: | 3724 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.38 - 7.14) | Sell |
| Bollinger Bands (100): | (4.96 - 6.7) | Buy |
Verrica Pharmaceuticals Technical Analysis
| Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Verrica Pharmaceuticals Stock
Is Verrica Pharmaceuticals Stock a Buy?
- Verrica Pharmaceuticals share price is 6.76 while VRCA 8-day simple moving average is 6.86, which is a Sell signal.
- The stock price of VRCA is 6.76 while Verrica Pharmaceuticals 20-day SMA is 6.93, which makes it a Sell.
- Verrica Pharmaceuticals 50-day simple moving average is 5.96 while VRCA share price is 6.76, making it a Buy technically.
- VRCA stock price is 6.76 and Verrica Pharmaceuticals 200-day simple moving average is 5.03, creating a Buy signal.
VRCA Technical Analysis vs Fundamental Analysis
Buy
55
Verrica Pharmaceuticals (VRCA)
is a Buy
Is Verrica Pharmaceuticals a Buy or a Sell?
-
Verrica Pharmaceuticals stock is rated a Buy
The current Verrica Pharmaceuticals [VRCA] share price is $6.76. The Score for VRCA is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Verrica Pharmaceuticals Stock Info
Market Cap:
286.76M
Price in USD:
6.76
Share Volume:
160.14K
Verrica Pharmaceuticals 52-Week Range
52-Week High:
7.76
52-Week Low:
2.86
Buy
55
Verrica Pharmaceuticals (VRCA)
is a Buy
Verrica Pharmaceuticals Share Price Forecast
-
What is the Verrica Pharmaceuticals stock price today?
The Verrica Pharmaceuticals stock price is 6.76 USD today. -
Will VRCA stock go up or go down?
Verrica Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Verrica Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Verrica Pharmaceuticals is not overvalued.
Is Verrica Pharmaceuticals Stock a Buy?
- Verrica Pharmaceuticals share price is 6.76 while VRCA 8-day exponential moving average is 6.87, which is a Sell signal.
- The stock price of VRCA is 6.76 while Verrica Pharmaceuticals 20-day EMA is 6.71, which makes it a Buy.
- Verrica Pharmaceuticals 50-day exponential moving average is 6.23 while VRCA share price is 6.76, making it a Buy technically.
- VRCA stock price is 6.76 and Verrica Pharmaceuticals 200-day simple moving average is 5.45, creating a Buy signal.
Fundamental Analysis of Verrica Pharmaceuticals
Is Verrica Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and an increase next year of $0.77 per share.
Technical Analysis of Verrica Pharmaceuticals
Should I short Verrica Pharmaceuticals stock?
- VRCA Moving Average Covergence Divergence (MACD) indicator is 0.25, suggesting Verrica Pharmaceuticals is a Buy
- Verrica Pharmaceuticals Relative Strength Index (RSI) is 54.8, which suggest Verrica Pharmaceuticals is overbought
- The Bollinger Bands (25) for Verrica Pharmaceuticals is (6.38 - 7.14), which suggest Verrica Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Verrica Pharmaceuticals is (4.96 - 6.7), which suggest Verrica Pharmaceuticals is a Buy
* Verrica Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.